ClinConnect ClinConnect Logo
Search / Trial NCT01689584

COsegregation of VARiants in Panel of Genes

Launched by INSTITUT CURIE · Sep 20, 2012

Trial Information

Current as of July 21, 2025

Recruiting

Keywords

Brca1 Brca2 Vus Co Segregation Genetic Counseling Palb2 Panel Of Genes

ClinConnect Summary

The COsegregation of VARiants in Panel of Genes (COVAR) trial is studying how to better understand specific gene changes that may increase the risk of certain cancers. These changes, known as variants, can sometimes be unclear in terms of their significance, which is why this research aims to classify them accurately. The information gathered from this study will help doctors give better advice to patients and their families about managing their cancer risk, and in some cases, it could even lead to the recommendation of preventive surgeries.

To participate in this trial, you must be at least 18 years old and either have a specific gene variant linked to cancer (known as an "index case") or be a family member of someone who does. If you're selected, you'll be asked to provide written consent to take part in the study. The trial is currently looking for participants, and it's open to all genders. If you join, you can expect to help advance our understanding of genetic risks for cancer, which could ultimately benefit many families facing similar challenges.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Index cases:
  • A person carrying a gene variant class 3 or 4, present and selected in the families of national database of genetic group and cancer (GGC Unicancer) which identifies the variations of all genes from the panel of genes of all French laboratories.
  • Age ≥ 18 years.
  • Signed written inform consent "index case"
  • Related parties:
  • Any relative of an index case with cancer
  • Any relative without cancer related to an index case, retained by investigators, based on family structure and degree of related compared to the index case
  • Age ≥ 18 years
  • Information and signature of the informed consent "selected relatives"
  • Exclusion Criteria:
  • Minors
  • Persons deprived of liberty or under guardianship (including curators).
  • Absence of signed written inform consent

About Institut Curie

Institut Curie is a prestigious French research institute dedicated to the fight against cancer, renowned for its integration of cutting-edge research, innovative therapies, and comprehensive patient care. Established in 1909, it combines academic excellence with clinical expertise, facilitating groundbreaking studies and clinical trials aimed at advancing cancer treatment and improving patient outcomes. With a multidisciplinary approach, Institut Curie collaborates with leading scientists and healthcare professionals, fostering a dynamic environment for the development of novel therapeutic strategies and personalized medicine in oncology. Its commitment to research and patient-centered care positions Institut Curie as a pivotal player in the global cancer research community.

Locations

Nice, , France

Clermont Ferrand, , France

Paris, , France

Tours, , France

Paris, , France

Vandoeuvre Les Nancy, , France

Paris, , France

Grenoble, , France

Marseille, , France

Paris, , France

Limoges, , France

Villejuif, , France

Rennes, , France

Bordeaux, , France

Lille, , France

Marseille, , France

Rouen, , France

Bordeaux, , France

Colmar, , France

Paris, , France

Lille, , France

Lyon, , France

Niort, , France

Orléans, , France

Caen, , France

Le Havre, , France

Poitiers, , France

Montpellier, , France

Nantes, , France

Reims, , France

Valence, , France

Reims, , France

Dijon, , France

Lyon, , France

Saint Cloud, Haut De Seine, France

Paris, Ile De France, France

Amiens, , France

Angers, , France

Angoulême, , France

Avignon, , France

Besancon, , France

Bourges, , France

Brest, , France

Chambery, , France

La Rochelle, , France

Nîmes, , France

Reims, , France

Saint Herblain, , France

Saint étienne, , France

Strasbourg, , France

Strasbourg, , France

Toulouse, , France

Troyes, , France

Vandoeuvre Les Nancy, , France

Pointe à Pitre, , Guadeloupe

Fort De France, , Martinique

Saint Pierre, , Réunion

Patients applied

0 patients applied

Trial Officials

Dominique STOPPA-LYONNET, PU-PH

Study Chair

Institut Curie

Sandrine CAPUTO, PhD

Study Director

Institut Curie

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials